Zeer Recursion / intent / recursion

Recursion

501-1000 employees·Salt Lake City, Utah, United States·recursion.com

Observed, not inferred · updated weekly

Buying intent

13 tracked signals | Top 10 topics are below | Engineering and Marketing are carrying most of it.

13signals · 30 days
10topics tracked
44.44%attributed to a team

Attention by team

LinkedIn activity, by team

Where Recursion's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Internal Communications
Artificial Intelligence
Corporate Video
Computer Vision
Software Development
Hiring
Engineering
Engineering to Internal Communications: no signal
High50% of team Engineering to Artificial Intelligence: High, 50% of this team's signals
Engineering to Corporate Video: no signal
High50% of team Engineering to Computer Vision: High, 50% of this team's signals
Engineering to Software Development: no signal
Engineering to Hiring: no signal
Marketing
High50% of team Marketing to Internal Communications: High, 50% of this team's signals
Marketing to Artificial Intelligence: no signal
High50% of team Marketing to Corporate Video: High, 50% of this team's signals
Marketing to Computer Vision: no signal
Marketing to Software Development: no signal
Marketing to Hiring: no signal
Others
High20% of team Others to Internal Communications: High, 20% of this team's signals
High20% of team Others to Artificial Intelligence: High, 20% of this team's signals
High20% of team Others to Corporate Video: High, 20% of this team's signals
Others to Computer Vision: no signal
High20% of team Others to Software Development: High, 20% of this team's signals
High20% of team Others to Hiring: High, 20% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Internal Communications
LinkedIn
High volume
96%
last
25d ago
Artificial Intelligence
LinkedIn
High volume
96%
last
17d ago
Corporate Video
LinkedIn
High volume
98%
last
25d ago
Computer Vision
LinkedIn
Medium volume
98%
last
17d ago
Software Development
LinkedIn
Medium volume
94%
last
12d ago
Hiring
LinkedIn
Medium volume
92%
last
12d ago
Software Developers
LinkedIn
Medium volume
94%
last
12d ago
Quality Score
LinkedIn
Medium volume
98%
last
24d ago
Thought Leadership
LinkedIn
Medium volume
98%
last
19d ago
Carbon Credits
LinkedIn
Medium volume
98%
last
24d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Recursion

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others3 active
Leadershipresearching Software Development
in
researching Artificial Intelligence
in
researching Corporate Video
in
Engineering1 active
researching Computer Vision
in
Marketing1 active
Senior ICresearching Corporate Video
in
Data1 active
Executiveresearching Carbon Credits
in

Primary products / business lines

LinkedIn company profile

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from i

Top accounts researching Recursion

names withheld on the public page

These are companies whose own people brought up Recursion unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

  • Account withheldKalamuna1 contacts
  • Account withheldDUNCAN FAMILY MEDICINE & INTEGRATIVE HEALTH, PLLC1 contacts
  • Account withheldCiti1 contacts
  • Account withheldColgate1 contacts
  • Account withheldSuki1 contacts
  • Account withheldDHL1 contacts
  • Account withheldbyteXL1 contacts
  • Account withheldCodegnan1 contacts
  • Account withheldKarl Wieser Snc1 contacts
  • Account withheldInformatica1 contacts
  • Account withheldPwC1 contacts
  • Account withheldZestIoT1 contacts
  • Account withheldInformation Technology Institute (ITI)1 contacts

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Recursion.

Company size breakdown
Buyer seniority mix

Companies researching Recursion

by employee count
  • 1-10 employees3 cos · 3 contacts
  • 11-50 employees2 cos · 2 contacts
  • 201-500 employees2 cos · 2 contacts
  • 51-200 employees1 cos · 1 contacts
  • 1,001-5,000 employees1 cos · 1 contacts

Who inside those companies

seniority, where on file
Senior IC
2
~11 further brand-affiliated researchers have no seniority on file and are excluded from these bars.

Buying committee functions

Employee job titles (LinkedIn)

Leadership — 2 people; Engineering — 1 person; Data / Analytics — 1 person

What's been said

public posts mentioning Recursion

Up to 9 public excerpts naming Recursion from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

It was a real treat to be back on stage at Fierce Biotech talking investor and capital markets communication. A few things I keep coming back to during the conversation: 🔹 Tech investors and biotech investors still don't speak the same language. But they're getting closer. Tech investors wants platforms: scalable, repeatable, fast. The extreme? Push a button, cure cancer. Biotech investors wants assets and clinical conviction. The extreme? Ignore where the puck is going and dismiss what AI is genuinely changing about drug discovery. The truth as usual sits in the middle. We're not clicking drugs into existence yet. But dismissing the real evolution happening in this space is too conservative. The art is finding language that brings the majority along without alienating either side. That's the challenge for comms professionals. And it’s an exciting one. 🔹 A great pitch isn't enough anymore and that's why owned channels matter. To be clear, earned media still matters enormously, but shrinking newsrooms mean you can't rely on it alone to tell your story. Owned channels give you the space to go deeper than a headline and explain the tech and science. Increasingly, they matter for another reason: as AI-driven search reshapes how people find information, optimizing your owned content for generative engines ( #GEO ) is becoming as important as SEO once was. At Recursion , we've been invested in telling our story on platforms like #LinkedIn , #Instagram and #YouTube for exactly this reason. The audience is interested, engaged and growing; and the opportunity to tell richer stories has been rewarding. 🔹 "It's not about you." Full stop. I'll keep saying it. The best communicators obsess over their audience and keep their goals clear. If you want to build a bridge, you have to speak the language of the person on the other side. Being a strategic communications partner means helping a team understand who they're talking to and how to actually reach them. It's sometimes an uncomfortable conversation. Have it anyway. 🙏 Thanks to my fellow panelists Michael Levey ( Merck ), Victoria Fort ( Ovid Therapeutics ), Susan Hager ( Andreessen Horowitz ), and Karin Hellsvik ( Foghorn Therapeutics Inc. ) for a fun conversation.

May 2026
LinkedIn

Massive congratulations to Najat Khan, PhD! No one that knows her would be surprised and we are lucky to have her at Recursion

Nov 2025
LinkedIn

It has been fantastic working with a powerhouse like Najat Khan, PhD and I know her combination of business and technical expertise will drive Recursion forward. Under Chris Gibson's leadership, we have made incredible progress on his vision and I'm very glad he will continue to support the company as Chairman for years to come. We have had a solid 2025, achieving difficult milestones with novel technologies while also implementing a disciplined operating model and solidifying our capital position. I'm excited to be a part of all the ways we will push the industry forward in the months and years to come.

Nov 2025
LinkedIn

So proud to work for Recursion 🎉👏🧬

Oct 2025

About this data. Recursion (recursion.com). Department attribution is 44.44%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries